READ MOREArticles21st March 2019Mark Cushway Challenges the Place of Duty in LeadershipDoes doing your duty mean doggedly pursuing an aim even if the evidence around you, and the opinions of others are telling you otherwise? Current affairs often centre on the issue of whether someone in a prominent position is doing their duty, or whether their interpretation of this duty is correct when it comes to […]
READ MOREArticles22nd November 201670% of Students Are Already ‘Skint’ and Living in Their OverdraftResearch shows that prospective students had big expectations for student life. 101,000 students in the UK expected to live in a modern city centre apartment, with no financial worries, and assumed their parents would contribute nearly £200 a month to their luxury lifestyle. They also expected a wild social life with nights out three times a week, sex nearly every day, and an annual salary of £25,000 to look forward to once they graduate.
READ MOREArticles31st July 2023Dubai’s Real Estate Market Thrives Amid Global Economic ShiftsDespite global economic uncertainties and the impact of rising interest rates in central banks worldwide, the property market in Dubai, United Arab Emirates (UAE), continues to thrive. According to the Bank for International Settlements, residential property prices in the UAE have surged by 28% over the past two years. This impressive growth outperforms both advanced […]
READ MOREArticles6th July 2016Business Elite Pharmaceutical MD of the Year 2016RelonChem has been in business since 2002
with their offices based in Widnes, Cheshire. As
an independent generic company they manufacture
and distribute therapeutic products to deal
with diabetes, pain management, hypertension,
gastric ulcer, breast cancer, immunosuppressant’s,
fungal infections, viral infections such as
cold sores, osteoporosis and prostate disorders.
READ MOREArticles1st May 2015NephroGenex Announces Proposed Offering of Common StockNephroGenex, Inc., a pharmaceutical company focused on the development of therapeutics to treat kidney disease, today announced that it has commenced an underwritten public offering of shares of its common stock and expects to raise gross proceeds of up to $30 million. In addition, NephroGenex expects to grant the underwriters a 30-day option to purchase up to an additional $4.5 million of shares of its common stock in connection with the offering. All of the shares in the offering will be sold by NephroGenex.
READ MOREArticles1st June 2020How can tech help people manage finances during isolation?Yiannis Faf, CEO, What We Want The spread of coronavirus has caused an incredible amount of disruption to lives and economies worldwide. The British Government has taken far-reaching steps in an effort to minimise the impact on the UK in both regards, by encouraging the population to practise isolating. Such a massive overhaul of day-to-day […]
READ MOREArticles2nd April 2014Service Delivery Trumps Offerings says StudyHow firms deliver service is the greatest differentiator between the state of the art and the state of the industry in family wealth management, according to a new report from the Family Office Exchange.
